Newsby HottubFor agents

The Plain Dealer

Ozempic, Wegovy and Zepbound get new FDA warning over rare condition

The FDA is requiring new warnings for GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound over a potential increased risk of a rare eye condition that can cause permanent vision loss.

Add to CRM by Hottub

Everyone in this article who could become a relationship. Add opens CRM by Hottub's form, filled in; nothing is saved until you press Add there.

  • Chris PughReporter, The Plain Dealer
    Add
  • The Plain DealerOutlet
    Add